Issue 19, 2017, Issue in Progress

Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach

Abstract

Correction for ‘PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach’ by Arunkumar Rengaraj et al., RSC Adv., 2017, 7, 5046–5054.

Associated articles

Article information

Article type
Correction
Submitted
01 Feb 2017
Accepted
01 Feb 2017
First published
13 Feb 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 11281-11281

Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach

A. Rengaraj, B. Subbiah, Y. Haldorai, D. Yesudhas, H. J. Yun, S. Kwon, S. Choi, Y. Han, E. Kim, H. Shenpagam N. and Y. S. Huh, RSC Adv., 2017, 7, 11281 DOI: 10.1039/C7RA90017A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements